Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F0ADL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,213
Award facts
- Contract value 100% obligated
- $13,213.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,213.22 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for XIFAXAN 550 MG tablets (60-count).
The order is placed against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of April 7, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F0ADL?
SPE2DR26F0ADL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 6, 2026.
How much is contract SPE2DR26F0ADL worth?
The government has obligated $13,213 on SPE2DR26F0ADL.
Is contract SPE2DR26F0ADL an order under another contract?
Yes. SPE2DR26F0ADL is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0ADL competed?
The extent of competition for SPE2DR26F0ADL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award